Gastrointestinal Cancer and ASCO 2022

The GI Cancer Channel on VJOncology is supported by Seagen. This supporter has no influence over the production of the content.

View overview page
4:53
Phase I trial of mRNA neoantigen vaccines for pancreatic cancer
Vinod P. Balachandran • 16 Jun 2022
3:17
Development of individualized mRNA neoantigen vaccines for pancreatic cancer
Vinod Balachandran • 16 Jun 2022
1:31
Potential of immunotherapy for pancreatic cancer
Vinod P. Balachandran • 16 Jun 2022
1:13
Next steps for the development of individualised mRNA neoantigen vaccines
Vinod P. Balachandran • 16 Jun 2022
2:01
Salvage CT041 CLDN18.2-specific CAR T-cell therapy for patients with advanced GI malignancies
Gregory P. Botta • 13 Jun 2022
0:34
Expanding indications for a CLDN18.2-specific CAR T-cell therapy in GI cancers
Gregory P. Botta • 13 Jun 2022
2:16
Safety and efficacy of a CLDN18.2-specific CAR T-cell therapy in GI adenocarcinoma
Gregory P. Botta • 13 Jun 2022
0:55
Future directions for CLDN18.2-specific CAR T-cell therapy in GI cancers
Gregory P. Botta • 13 Jun 2022
0:47
Remaining areas of unmet need for patients with locally advanced pancreatic cancer
Rainer Fietkau • 6 Jun 2022
2:25
CONKO-007: chemoradiotherapy increases rates of R0 resection in locally advanced pancreatic cancer
Rainer Fietkau • 6 Jun 2022
0:42
FOLFIRINOX, gemcitabine + paclitaxel to enhance surgery outcomes for locally advanced PC
Rainer Fietkau • 6 Jun 2022
1:16
Colorectal cancer updates at ASCO 2022
Mark Yarchoan • 5 Jun 2022
2:43
PARADIGM: Panitumumab plus mFOLFOX6 in RAS wt mCRC
Chiara Cremolini • 4 Jun 2022
1:05
How will the PARADIGM trial change the mCRC treatment landscape?
Chiara Cremolini • 4 Jun 2022
0:50
Differential treatment options for left- and right-sided mCRC
Chiara Cremolini • 4 Jun 2022
1:30
How far away are we from implementing CTC-based approaches in prostate cancer?
Anis Hamid • 6 Jun 2022

The GI Cancer Channel on VJOncology is supported by Seagen.

This supporter has no influence over the production of the content.

The content of VJOncology is intended for healthcare professionals